Design and registration
We intended to perform a systematic and critical review of randomized controlled clinical trials, comparing long term results for surgical repair vs. rehabilitation for large or massive degenerative rotator cuff tears. The review was submitted to PROSPERO and registered under the number CRD42020146161.
Information sources and search
Searches were made in the PubMed, Embase, PEDro and Cochrane Library databases to identify articles until March 2020. Two types of keywords were used: MeSH terms and free text and their subheadings. This search was made with the help of a librarian of Paris-Saclay University with regard to the search algorithm. The terms included rotator cuff injuries/surgery, rotator cuff tear, surgery, surgical procedures/operative, general surgery, surgery, outcomes, conservative, conservative treatment, and randomized clinical trial. The search concerned only English language and human studies.
Inclusion and exclusion criteria are described in the Table 1.
Table 1
Inclusion criteria
|
• Randomized controlled clinical trials that compare surgical repair vs rehabilitation.
• Studies in hospitals, clinics, rehabilitation centers.
• Pathologies concerning degenerative rotator cuff tears with patients over 50 years old.
• Studies that include and report on large or massive rotator cuff tears diagnosed by RMI, arthro-scanner, or ultrasound.
• Studies that describe at least one of the following outcomes of the treatments: strength, pain, or function.
• Articles that describe the evolution and complications of the treatment i.e. aggravation of the tears diagnosed by RMI, arthro-scanner, ultrasound.
• For surgical articles: arthroscopy or open rotator cuff repair with or without debridement.
• For conservative treatment: rehabilitation with exercise with or without injections and/or anti-inflammatory, antalgic drugs.
|
Exclusion criteria
|
• Studies that do not describe the type of the tears.
• Studies that include patients who had previous surgical repair of the rotator cuff.
• Studies that include patients who suffer from other pathologies than degenerative rotator cuff tears i.e. traumatic causes or young patients.
• Duration of follow up of < 1 year.
• Sample size at baseline < 50.
|
The first author did a preliminary selection on the basis of titles and abstracts. Whole texts were read, when there were doubts about the inclusion and exclusion criteria. The inclusion criteria in the preliminarily selected articles were then controlled independently by one of the two other authors on the basis of the full texts. The opinion of the third author could be requested in case of disagreement on the inclusion of an article. We manually screened the references of each included study to ensure that no studies were missed. The Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) 2009 was followed and Fig. 1 shows the entire selection process and the reasons for exclusions.
Data extraction
The main outcomes of interest were changes in pain (VAS or other validated scores) and validated functional scores from baseline to the last available outcome, whether they were reported as exact estimates or differently, e.g. as odds ratios or relative risks. An additional outcome concerned the complication rate in each group.
We intended to extract three types of information: i) descriptive information of included articles, and ii) information on internal validity and overall assessment of the study (Table 2). A specific checklist was established to assess the studies according to the methodological requirements for randomized controlled clinical studies. This checklist was based on existing recommendations in the SIGN statement (15).
Table 2
Adapted checklist from SIGN Methodology checklist for randomized clinical trials.
Section 1: Internal validity
1. The study addresses an appropriate and clearly focused question.
2. The assignment of subjects to treatment groups is randomised.
3. An adequate concealment method is used.
4. The design keeps subjects and investigators ‘blind’ about treatment allocation.
5. The treatment and control groups are similar at the start of the trial.
6. The only difference between groups is the treatment under investigation.
7. All relevant outcomes are measured in a standard, valid and reliable way (arthrography, MRI, ultrasound).
8. Was the percentage of the individuals or clusters recruited into each treatment arm of the study who dropped out before the study completion inferior to 20%?
9. All the subjects are analysed in the groups to which they were randomly allocated (often referred to as intention to treat analysis).
10. Where the study is carried out at more than one site, results are comparable for all sites.
|
( ) Yes, ( ) no, ( ) can’t say
( ) Yes, ( ) no, ( ) can’t say
( ) Yes, ( ) no, ( ) can’t say
( ) Yes, ( ) no, ( ) can’t say
( ) Yes, ( ) no, ( ) can’t say
( ) Yes, ( ) no, ( ) can’t say
( ) Yes, ( ) no, ( ) can’t say
( ) Yes, ( ) no, ( ) can’t say
( ) Yes, ( ) no, ( ) can’t say
( ) Yes, ( ) no, ( ) can’t say
( ) Does not apply
|
Section 2: Overall assessment
2.1 How well was the study done to minimise bias?
2.2 Taking into account clinical considerations, your evaluation of the methodology used, and the statistical power of the study, are you certain that the overall effect is due to the study intervention? (clinical considerations: Are the results clinically different between the two groups? Is the complication rate superior in surgery or rehabilitation treatment?)
2.3 Are the results of this study directly applicable to the patient group targeted by this guideline?
2.4 Notes. Authors’ conclusions. Add any comments on your own assessment of the study, and the extent to which it answers your question and mention any areas of uncertainty raised above. (authors’ interpretation was consistent with results benefit and harm, time of follow-up)
|
High quality (++)≤
Acceptable (+)≤
Low quality (-)≤
Unacceptable – reject 0 ≤
( ) certain, ( ) uncertain
( ) Yes, ( ) no
|
All outcome measurements and results (differences in the score, main effect, 95%CI or p-values, when 95% CI were not reported or could not be computed), would be recorded directly into evidence tables. In addition, losses and exclusions would be noted and how the authors dealt with this.
Relevant information regarding study descriptions and method would be sought in the Methods section in the main text and information on results obtained from the Result section in the main text. Two readers would collect this information (KV and CLY), independently of each other, and in case of disagreement, discussions could be held with the third author (OG).
1 The list of descriptive items of included articles consisted of the following items:
-
First author.
-
Year of publication.
-
Setting and location(s) where the study was performed.
-
Sample size.
-
Type of population at baseline.
-
Interventions and types of treatment in the comparative groups.
-
Time of follow up(s).
2 The quality assessment (SIGN Statement) included some minor changes. Concerning item 1.7 of Sect. 1 (Valid diagnostic tools for rotator cuff tears) we specified: RMI, arthro-scanner or ultrasound.
Item1.8 was changed from “What percentage of the individuals or clusters recruited into each treatment arm of the study dropped out before the study was completed? Yes/No/Can’t say” to “Was the percentage of the individuals or clusters recruited into each treatment arm of the study who dropped out before the study completion inferior to 20%? Yes/no/Can’t say”. This made it easier to answer the question and because, conventionally, a 20% drop out rate is regarded as acceptable (16).
Data analysis and interpretation of findings
Based on the above information, we aimed to distinguish the studies for which the overall quality was the best from those with lower quality, without introducing an exact cut-point. Nevertheless, we considered that if the response for the item 1.2 (The assignment of subjects to treatment groups is randomized) was “no” or “can’t say”, the study would be considered as unacceptable. Otherwise, the evaluation of studies would be based on an overall consideration of the credibility of data and obtained through consensus discussions, if necessary.
We would establish any difference in treatment outcome in each study and if this difference favored surgical repair or rehabilitation. We would then endeavor to calculate the odd ratios for this result and if possible, the number needed to treat. We would also calculate the number of reported complications in each study.
Concerning clinical significance, we planned to record if there were any differences between the groups, and if so, if these were statistically and clinically significant.